Custirsen (OGX-011) : a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer

Robert Zielinski, Kim N. Chi

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Custirsen (OGX-011) : a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry